|
Magyar Gyermekorvosok Társasága |
|
Magyar Gyermekorvosok Társasága, 2010. évi Nagygyűlés |
Rendezvény kezdete: 2010.09.23. | Rendezvény vége: 2010.09.25. |
Szakterület(ek): Gyermekgyógyászat |
Szervező: Hohol Róbert |
Tel: 06 (1) 214 7701 |
E-mail: hoholr@diamond-congress.hu |
Helyszín: 2500 Esztergom, Szent István tér 10 |
A rendezvény Web oldala: http://www.diamond-congress.hu/mgyt/ |
Témák
•Baleset-megelőzés és kardiovaszkuláris prevenció gyermekkorban
•Neonatológia aktuális kérdései
•Klinikai genetika, anyagcsere, ritka betegségek
•Calcium-anyagcsere és D-vitamin háztartás
•Görcsállapotok differenciál-diagnosztikája, epilepszia
•Allergia, immunológia, védőoltások, H1N1-influenza
•Szepszis
•Célzott gyógyszeres kezelés, farmakogenetika
•Határterületek és komplementer (fizioterápiás, pszichoszociális és dietetikai) ellátás a gyermekgyógyászatban
•Gyermekellátás a gazdasági válságban
Regisztráció
Részvételi díjak (bruttó) | május 31-ig | augusztus 31-ig | szept. 1-től | MGYT tag | 29 000 | 35 000 | 39 000 | Nem MGYT tag | 35 000 | 41 000 | 45 000 | 35 év alatti, nyugdíjas, szakdolgozó | 22 000 | 25 000 | 28 000 | Napijegy | 12 000 | 15 000 | 18 000 | Kísérő | 9 000 | 11 000 | 13 000 |
A regisztráció és az absztraktok beküldése a kongresszus weboldalán >> lehetséges.
Absztraktok beküldési határideje: 2010 április 15.
Bővebb információ az absztrakt bejelentéssel kapcsolatban ide kattintva >> olvasható.
Az akkreditálás folyamatban van, várható kreditérték: 50 pont
A rendezvény web-oldala: http://www.diamond-congress.hu/mgyt |
|
|
 |
|
Magyar Immunológiai Társaság |
|
1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
 |
|
Magyar Immunológiai Társaság |
|
1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
 |
|
Magyar Immunológiai Társaság |
|
1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
 |